Cancer Immunotherapy Guidelines Bladder Carcinoma Expert Panel

SITC Cancer Immunotherapy Guidelines are a collection of consensus statements developed by experts in the treatment of specific types of cancer. Each consensus statement provides key indicators to help practicing oncologists determine when and how to best use immunotherapy to treat their patients. These systematically developed recommendations promote enhanced clinical decisions concerning patient selection, toxicity management, clinical endpoints, and the sequencing or combination of therapies. The Bladder Cancer Expert Panel was developed to generate a consensus statement specifically for bladder cancer.


Ashish M. Kamat, MD, MBBS
The University of Texas MD Anderson Cancer Center

Jonathan E. Rosenberg, MD
Memorial Sloan Kettering Cancer Center